The FDA draft guidance "Considerations for Complying with 21 CFR 211.110" raises points to consider regarding drug products ...

With the rise of robotic and minimally invasive surgery and other innovations, medicine has moved into the 21st century.

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

D Systems introduces the NextDent Jetted Denture Solution in the U.S., offering dental labs a fast, cost-effective way to ...

Quality Control Market Size is projected to grow at a CAGR of 6.66 Market Research®. The report reveals that the market was ...

Explore how AI in pharma manufacturing is being deployed with digital twins and predictive tools, which is reshaping CDMO timelines and sponsor expectations.

Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, ...

As manufacturers shore up investments in emerging technologies and domestic production capacity, a strategic EAM approach is ...

Discover Quince Therapeutics’ breakthrough drug-delivery platform aiming to safely treat rare diseases with encapsulated steroids.

Despite AI's diagnostic prowess in benchmarks, real-world hurdles in regulation, liability, and workflow mean it's augmenting ...

Following up on a June announcement of their collaboration, the Joint Commission and the Coalition for Health AI (CHAI) have ...

FluidAI Medical announced it received FDA 510(k) clearance for its Origin real-time monitoring system for patients recovering ...